Novavax Inc - ESG Rating & Company Profile powered by AI
The webpage contains a Q&A section on Novavax Inc. Scroll down to the end of the webpage for potential risks for Novavax Inc based on sector, geography and marketcap. Alternative companies in the rating industry group for Novavax Inc are shownin the table.
Novavax Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 4.0, social score of 4.0 and governance score of 5.7.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 837 | Zentiva as | 4.7 | High |
| 837 | Zogenix Inc | 4.7 | High |
| 852 | Novavax Inc | 4.6 | High |
| 852 | Canopy Growth Corp | 4.6 | High |
| 852 | Matinas BioPharma Holdings Inc | 4.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Novavax Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Novavax Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Novavax Inc report the average age of the workforce?
Sign up for free to unlockDoes Novavax Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Novavax Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Novavax Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Novavax Inc offer flexible work?
Sign up for free to unlockDoes Novavax Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Novavax Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Novavax Inc conduct supply chain audits?
Sign up for free to unlockDoes Novavax Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Novavax Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Novavax Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Novavax Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Novavax Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Novavax Inc disclose water use targets?
Sign up for free to unlockDoes Novavax Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Novavax Inc have a product recall in the last two years?
Sign up for free to unlockDoes Novavax Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Novavax Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Novavax Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Novavax Inc disclose parental leave metrics?
Sign up for free to unlockDoes Novavax Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Novavax Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Novavax Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Novavax Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Novavax Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Novavax Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Novavax Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Novavax Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Novavax Inc disclose its waste policy?
Sign up for free to unlockDoes Novavax Inc report according to TCFD requirements?
Sign up for free to unlockDoes Novavax Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Novavax Inc disclose energy use targets?
Sign up for free to unlockDoes Novavax Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Novavax Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Novavax Inc
These potential risks are based on the size, segment and geographies of the company.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.